These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 4609941

  • 21. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior.
    Davis WM, Borgen LA.
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):453-62. PubMed ID: 4445565
    [No Abstract] [Full Text] [Related]

  • 22. Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery.
    Gregg JM, Small EW, Moore R, Raft D, Toomey TC.
    J Oral Surg; 1976 Apr; 34(4):301-13. PubMed ID: 1062533
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical pharmacodynamic effects of delta-9-tetrahydrocannabinol].
    Ladewig D, Hobi V, Faust V, Kocher R, Richter R.
    Lebensversicher Med; 1973 Mar; 25(2):37-40. PubMed ID: 4144642
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of the hypothermic action of tetrahydrocannabinols in mice and squirrel monkeys.
    Haavik CO, Hardman HF.
    J Pharmacol Exp Ther; 1973 Dec; 187(3):568-74. PubMed ID: 4203720
    [No Abstract] [Full Text] [Related]

  • 27. [Comparison of altered states of consciousness induced by short-term sensory deprivation and (-)-delta9-trans-tetrahydrocannabinol].
    Dittrich A.
    Z Exp Angew Psychol; 1975 Dec; 22(4):547-60. PubMed ID: 1232717
    [No Abstract] [Full Text] [Related]

  • 28. Psychological adverse effects of cannabis smoking: a tentative classification.
    Nigrete JC.
    Can Med Assoc J; 1973 Jan 20; 108(2):195-6 passim. PubMed ID: 4569453
    [Abstract] [Full Text] [Related]

  • 29. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.
    Psychopharmacology (Berl); 2002 Dec 20; 164(4):407-15. PubMed ID: 12457271
    [Abstract] [Full Text] [Related]

  • 30. LSD.
    Med Lett Drugs Ther; 1967 Jan 13; 9(1):1-2. PubMed ID: 6040593
    [No Abstract] [Full Text] [Related]

  • 31. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ, Kochar MS, Wang RI.
    Clin Pharmacol Ther; 1973 Jan 13; 14(3):344-52. PubMed ID: 4698562
    [No Abstract] [Full Text] [Related]

  • 32. [Cannabis--clinical pharmacology].
    Retterstol N.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2125-6. PubMed ID: 4590073
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Pharmacology of the active substances of cannabis].
    Schönhöfer PS.
    Arzneimittelforschung; 1973 Jan 10; 23(1):50-6. PubMed ID: 4579626
    [No Abstract] [Full Text] [Related]

  • 35. Hypothermic effects of marihuana, marihuana derivatives and chlorpromazine in laboratory mice.
    Liu RK.
    Res Commun Chem Pathol Pharmacol; 1974 Oct 10; 9(2):215-28. PubMed ID: 4438829
    [No Abstract] [Full Text] [Related]

  • 36. Psychological effects of tetrahydrocannabinol.
    Waskow IE, Olsson JE, Salzman C, Katz MM.
    Arch Gen Psychiatry; 1970 Feb 10; 22(2):97-107. PubMed ID: 5410582
    [No Abstract] [Full Text] [Related]

  • 37. Human EEG spectra before and during cannabis hallucinations.
    Koukkou M, Lehmann D.
    Biol Psychiatry; 1976 Dec 10; 11(6):663-77. PubMed ID: 999986
    [Abstract] [Full Text] [Related]

  • 38. High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients.
    Ablon SL, Goodwin FK.
    Am J Psychiatry; 1974 Apr 10; 131(4):448-53. PubMed ID: 4592555
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.